The adaptive immune system relies on diversity of its repertoire of receptors to protect the organism from a great variety of pathogens. Since the initial repertoire is the result of random gene rearrangement, binding of receptors is not limited to pathogen-associated antigens but also includes self antigens. There is a fine balance between having a diverse repertoire, protecting from many different pathogens, and yet reducing its self-reactivity as far as possible to avoid damage to self. In the ageing immune system this balance is altered, manifesting in reduced specificity of response to pathogens or vaccination on a background of higher self-reactivity. To answer the question whether age-related changes of repertoire in the diversity and self/non-self affinity balance of antibodies could explain the reduced efficacy of the humoral response in older people, we construct a minimal mathematical model of the humoral immune response. The principle of least damage allows us, for a given repertoire of antibodies, to resolve a tension between the necessity to neutralise target antigens as quickly as possible and the requirement to limit the damage to self antigens leading to an optimal dynamics of immune response. The model predicts slowing down of immune response for repertoires with reduced diversity and increased self-reactivity.
D R A F T
functions have been used in immune system modelling in the past, such as the 'total affinity' in somatic hypermutation of B cells (14) , or the 'disagreement' between the B and T cell signalling in lymphocyte 'networks' in more recent studies (15) (16) (17) .
Furthermore, we assume that we have many types of Abs, each specified by its affinity to the targets and to self Ag (18) , which constitute the immune repertoire in our model. Immune repertoires were studied theoretically in e.g. (19, 20) , and more recently in (21) . The role of self-Ags in shaping the diversity of repertoires, important for reliable self/non-self discrimination (19) , was emphasised in (20) . We assume that both the binding of Abs to self-Ag and the presence of free target Ag incurs damage, hence the unconstrained use of Abs is not possible and the amount of free target Ag has to be reduced. To resolve these two conflicting requirements we develop the principle of least damage which allows us to derive an optimal dynamics of the immune response. While the resulting theoretical framework is very general, even its simplest analytically solvable version predicts the 'slowing down' of the immune response for repertoires with reduced diversity and increased self-reactivity.
Mechanics of Immune Response
A simple thought experiment. To investigate the trade-off between antibody binding to a desired target, such as pathogen, versus a self-damaging target, we consider the case where there are many antibodies responding to a challenge, in the absence of a single dominating high-affinity antibody. Our thought experiment assumes that we have a finite volume reservoir containing a finite amount of target antigen (Ag) and self-antigen (self-Ag) in some medium (see Figure 1 ). We also assume that we are given M different types of antibodies (Abs), labelled by the integers 1 to M , which can be released into the reservoir. The release of each Ab is controlled by a valve. We assume that the reservoir contents are well mixed. Abs released into the reservoir react with both types of Ag, resulting in the formation of Ag-Ab complexes; thus the amount of 'free' (i.e. unbound) Ag is reduced. The properties of Abs, such as how strongly they react with each Ag, etc., are assumed to be initially unknown. Two gauges attached to the reservoir measure the amounts of free target Ag and of self-Ag. The opening and closing of valves, and performing various measurements (such as of the amount of Abs delivered into the reservoir, the amount of free target Ag and self-Ag in the reservoir) constitutes an 'experiment'.
Measurement protocol. The experimental measurement is defined by a set of time points t0, . . . , t k−1 , t k , . . . , tn together with the flow rates rµ(t1), . . . , rµ(t k−1 ), rµ(t k ), . . . , rµ(tn) recorded at these times, for each Ab µ (see Figure 1 ). We label antibody types by Greek indices. The total amount of Ab µ released into the reservoir up to the time t k is given by the sum bµ(t k ) = k =1 rµ(t )(t − t −1 ). If the flow rates rµ(t) are smooth functions of time, each amount approaches an integral bµ(t k ) = t k t 0 rµ(t)dt in the limit where the measurement times become arbitrarily close, t − t −1 → 0. The system in Figure 1 is then fully described by the amounts of Abs b(t) = (b1(t), . . . , bM (t)), delivered into the reservoir up to time t, and the rates d dt b(t) = d dt b1(t), . . . , d dt bM (t) of delivery of Abs. The amount of free target Ag, measured by the left gauge in Figure 1 , is a function AT (b(t)) of the Abs b(t). The same is true for AS(b), the amount of free self-Ag, measured by the right gauge in the Figure 1 . By construction, the total amount of free Ag in the experiment is a non-increasing function of time, i.e. d dt AT ≤ 0 and d dt AS ≤ 0.
Measurement of antibody affinity. Let the amount of free target Ag at time t0 be AT (b(t0)), and assume that at the next time-point t1 we release into the reservoir a small amount ∆bµ of Ab µ, i.e. bµ(t1) = bµ(t0) + ∆bµ and bν (t1) = bν (t0) for all ν = µ. The resulting change in the amount of free target Ag is given by ∆A µ T = AT (b(t1)) − AT (b(t0)) ≤ 0 and for ∆bµ → 0 we have (∂AT /∂bµ)(dbµ/dt) ≤ 0. The same holds for the free self-Ag AS(b). Upon releasing a single Ab into the reservoir we will generally observe different behaviours of the gauges, which can be used to classify this Ab. Ab µ is more 'reactive' than Ab ν if ∆A µ T ≤ ∆A ν T , for ∆bµ = ∆bν , i.e. if the same amount of Ab reduces more Ag upon releasing type µ insterad of ν . Similarly, Ab µ is more self-reactive than Ab ν when ∆A µ S ≤ ∆A ν S , and Ab µ is more reactive than self-reactive when ∆A µ T ≤ ∆A µ S (and vice versa). For ∆bµ → 0 all of the above definitions can implemented with partial derivatives, so Ab µ is more reactive than self-reactive when (∂AT /∂bµ) ≤ (∂AS/∂bµ), etc.
Significance Statement
The older immune system is less able to protect us from infection and more likely to malfunction, and inappropriate inflammation is involved in the aetiology of many diseases of old age. Since the world population is growing older, immune senescence is a significant health risk. Previous studies, by us and others, show that the human antibody repertoire is less diverse and there are more antibodies that recognise self-antigens in older people. We posed the scenario that an antibody can bind multiple different targets, both self and non-self, but with varying affinity, and asked how efficacy of the immune system might be affected by this balance and by the loss of diversity of antibodies at a population level. Our theoretical framework was developed from first principles. It predicts that a reduced diversity and increased self-reactivity in the antibody pool will slow down immune responses to exogenous targets, thus providing an explanation for the reduced immune response to vaccines and infections in older people.
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Fig. 1.
Immune Response: the Thought Experiment. Top drawing: antibodies (Abs) are released into a reservoir which contains a mixture of target antigen, Ag (red triangles) and self-antigen, self-Ag (blue circles). They can form Ab-Ag complexes and thereby reduce the amount of free (i.e. unbound) Abs, target Ag and self-Ag. The latter two amounts are measured, respectively, by the left and right 'gauges'. The experiment is performed under constraints, such as finite duration and finite reservoir volume. Middle drawing: the release of antibodies is controlled by the flow rate (vertical axis) at any given time (horizontal axis). The total amount of Ab released up to time t k (crosses) is increasing with time. Bottom drawing: the amount of free target Ag (self-Ag) is decreasing with time. Each measurement is taken at the time-point s k with s k t k , to ensure
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The difference ∆A µ T is related to the affinity of Ab µ (22) , which is usually defined as the ratio rµ = K + µ /K − µ of forward/backward rates of the chemical reaction Ag + Ab AgAb. In chemical equilibrium the latter can be computed experimentally, via the relation rµ = [AgAb]/[Ag][Ab], upon measuring the amount [Ag] of free target Ag, the amount [Ab] of free Ab, and the amount [AgAb] of Ag-Ab complexes, in the absence of other antibodies or antigens. In our notation, the affinity can be written as
, [1] evaluated at b = 0. Thus for ∆bµ → 0 it becomes the derivative
.
[2]
For b = 0, expression [2] can be seen as a generalised affinity, measured by adding a small amount of Ab µ in to the mixture of Ags and Abs. The affinity to self-Ag r S µ (b) uses the same definition as [2] , but with AS(b) instead of AT (b). In immunology one commonly thinks in terms of a repertoire of different antibodies, each reacting to target-Ag or to self-Ag, and of changing repertoires representing expansions of target-Ag antibodies in immune activation and deletion of self-Ag antibodies in immune tolerance. However, single antibodies can bind to multiple different antigens, with varying affinity, and these antigens could be either target-Ag or self-Ag. What we may have empirically determined to be a specific target-Ag binding antibody may in fact be a polyspecific antibody where the binding to self-Ag is so small as to be unnoticed. So we need to consider polyspecific antibodies, with variable affinities for binding to multiple Ag.
Using multiple antibody types to reduce free antigen. We assume here for simplicity that we have one type of target Ag, which we seek to reduce using a repertoire of antibodies. The Ag has NA distinct regions which can be 'recognised' by Abs, the epitopes. The Abs, represented by the amounts b = (b1, . . . , bM ), are assumed to interact with free epitopes, i.e. those not bound by Abs. The amounts of the free epitopes are written as E = (E1, . . . , EN A ). Each Ei ≡ Ei(b) must be a non-decreasing function of the amount of Abs, such that 0 ≤ Ei(b) ≤ Ei(0). Furthermore, the 'amount' of free target antigen AT (b) ≡ AT (E (b)) ≥ 0 will similarly be a non-decreasing function of the amount of free epitopes.
We assume that the protocol used to reduce the amount of Ag takes the form of differential equations for the rates of antibody delivery, given the amounts b ≡ b(t) of Abs in the reservoir (as in biological processes), i.e. that
For the dynamics [3] to reduce target Ag, it is sufficient that the rate functions fµ(b) are positive,
Clearly, since AT (b) ≥ 0, the AT (b) is a Lyapunov function of [3] . The possible choices for the Ab delivery rate functions fµ(b) are further restricted by physical constraints in the experiment, such as finite time, finite volume, finite amount of available Abs, etc. Further complications occur if, in addition to target Ag, the reservoir also contains self Ag and, when we try to reduce free target Ag, only a finite amount of reduced self Ag (off-target damage) can be tolerated. It is natural to assume that the amount of free self Ag must depend in a similar way on the amount of free epitopes E S (b) = E S 1 (b), . . . , E S N S (b) as the target antigen, so AS(b) = AS E S (b) . Furthermore, one would expect that the Ab dynamics [3] is also a function of self-epitopes, i.e.
and that any biologically sensible choice fµ(. . .) must be an increasing function of E(b) and a decreasing function of E S (b).
Antibody Dynamics
Principle of least damage. Instead of guessing an equation for the Ab delivery rates fµ(. . .), we take a Darwinian approach and assume that an optimized mechanism will have evolved that reduces the target Ag as quickly as possible, to minimise the 'damage' done, while minimising the harmful binding to self Ag in the process. The optimization problem can be solved using mathematical tools from physics. To this end we consider all possible paths b(t), allowed by the setup in Figure 1 . Any such path will obey dbµ/dt ≥ 0 and dAT /dt ≤ 0, i.e. each will minimize AT (b) (which we will call the 'potential energy'). The latter is a property of the reservoir. We assume that the antibody delivery mechanism in Figure 1 has associated with it a 'kinetic energy' T (db/dt), which reflects the likely involvement of further variables governed by first order differential equations (equivalently, that the equations for bµ, if autonomous, will be at least second order). The path which begins at b(t0) at time t0 and ends in b(t1) at time t1 > t0, with AT (b(t0)) ≥ AT (b(t1)), can then be obtained (23) by minimising the action
where
is the Lagrangian (see Materials and Methods).
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Interpretation of the action. The area under the curve of AT (b(t)) on any path b(t), given by the integral [7] can be seen as a damage inflicted upon the organism during the time interval [t0, t1] by the presence of free target Ag. The intuition is that during any small time interval the damage inflicted by Ag is equal to the amount of free Ag times the time it spends in the organism. Definition [7] assumes moreover that this damage is cumulative, i.e. exposure to a large amount of Ag for a short time or a to a small amount of Ag for a longe time are equivalent. We observe that 0 ≤ DA ≤ AT (b(t0)) (t1 − t0), which follows from the properties AT (b(t)) ≥ 0 and AT (b(t0)) ≥ AT (b(t1)). So the path minimising the action [6] is the path which minimises the damage DA (t1 − t0), but subject to the constraint on db/dt enforced by the term (24) .
Similar to [7] , we can consider the integral
where 0 ≤ DS ≤ AS(b(t0)) (t1 − t0). From this integral follows the 'damage to self', defined for each small time interval as the amount of free self Ag reduced by off-target action of the Abs times the duration of this reduction. Thus during the interval
Determination of optimal antibody dynamics. We minimise the action [6] subject to the constraint [8] , i.e. we assume that removal of some amount of self Ag can be tolerated. This is equivalent (24) to minimisation of [6] with the Lagrangian
where γ is a Lagrange parameter. The solution of the minimization is described by the Euler-Lagrange equation (see Materials and Methods):
[10]
We note that the above second order differential equations that describe the optimal control of antibody release were derived from general system level principles, with only minimal and plausible assumptions. Their solution will involve 2M constants, fixed by the boundary conditions b(t0) and b(t1). The natural form for the kinetic energy is T (db/dt) = 1 2 M µ=1 Λµ(dbµ/dt) 2 , where Λµ > 0. It corresponds to assuming that at least one set of further (as yet unspecified) variables play a role in the Ab delivery process. Insertion into [10] gives us the 'Newtonian' equation
where we used the affinities [2] to express the partial derivatives in [10] . We note that the Λµ, which reflect properties of the Ab delivery mechanism, act to introduce 'inertia': large (small) Λµ reduce (increases) the tendency to change dbµ/dt. The total 'force' Λµ(d 2 bµ/dt 2 ) in [11] is a sum of a target Ag dependent term AT (b) rµ(b) that increases the rate of Ab delivery, and a self Ag dependent term −γAS(b) r S µ (b) which decreases Ab delivery (if γ > 0). The state of mechanical equilibrium Λµ(d 2 bµ/dt 2 ) = 0, marking the balance of forces in [11] , gives us, for AS(b), rµ(b) > 0, the identity
. [12] It follows that there exists a function α(b) such that rµ(b) = α(b) r S µ (b) for all µ. Furthermore, for b = 0 the latter gives us the relation rµ = α r S µ between affinities, where α = α(0).
Results
Free Ag reduced by large numbers of 'weak' antibodies.
To proceed with our model we need to determine the dependencies of AT and AS on the antibody amounts b = (b1, . . . , bM ). Here we consider M distinct univalent Abs Iµ, labelled by µ = 1, . . . , M , each interacting with the univalent target Ag ( ) and self-Ag (•), via the following chemical reactions
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In chemical equilibrium, given the initial concentrations AT (0) of the target Ag and AS(0) of the self-Ag, the concentrations AT (b) of free target Ag and AS(b) of self-Ag are obtained by solving the following recursive system of equations; see Supplementary Information (SI ), Section 1A:
Each Ab is characterised by its affinities to the target Ag, rµ = K + µ /K − µ (the ratio of forward and backward rates), and self-Ag,
These give rise to the affinity vectors r = (r1, . . . , rM ) and r S = (r S 1 , . . . , r S M ), which define the Ab repertoire. For multiple self-Ags the repertoire is a matrix of affinities (see SI, Sections 1A & 2A).
In order to use [11] one would prefer an explicit expression for AT (b) and AS(b), but how to solve the non-linear recursion [14] analytically is not clear. However, if we assume that affinities scale as rµ ≡ rµ/M and r S µ ≡ r S µ /M , then in the regime M → ∞ of having a large number of individually weak Abs, we obtain the concentrations of free Ags in explicit form (see Materials and Methods): [16] expressed as functions of the averages
The averages BT (b) and BS(b) can be seen as total affinities to the target Ag and the self Ag. A similar object, where bµ was the number of B cells with affinity to Ag rµ/M , was postulated as an 'energy' function of somatic hypermutation in (14) . We note that the result [16] , although derived for univalent Abs and Ag, is also true for multivalent Abs (see SI, Section 1B). Thus our model predicts that it is possible to reduce target antigen without requiring affinity-matured antibodies, such as those produced in a T-dependent reaction, if a sufficient number of weaker binders are available. Furthermore, the framework outlined here can easily incorporate multiple Ags, chemical species binding Ab-Ag complexes, phagocytes, etc. (see SI, Section 1A)
Reduced macroscopic description. Let us consider the Euler-Lagrange equations [11] for the free and self-Ag. Via [16] , and upon reverting from the right-hand side of [11] back to that of its predecessor [10] , these now take the form
, [17] where BT ≡ B(b) and BS ≡ BS(b). If we assume that Λµ scales as Λµ = λµφ(M )/M , where φ(M ) = o(M ), we can derive for M → ∞ the following equations (SI, Section 2A):
where in the above we used the dot product definition
We assume that at time t = 0 all Ab amounts and production rates are zero, i.e. bµ = dbµ/dt = 0 for all µ, so the initial conditions for [18] are BT (0) = BS(0) = 0 and (dBT /dt)(0) = (dBS/dt)(0) = 0. Furthermore, the average Ab concentratioñ
[19]
with the short-hand 1 = (1, . . . , 1). The simplest case to consider is that where each Ab is either self-reactive or non-self-reactive, i.e. for each µ either rµ > 0 or r S µ > 0, but never both. This implies that r · r S = 0, and that hence [18] decouples into two independent equations: 2 [20]
The dynamics of BT is now conservative, with energy function [21] where the terms (dBT /dt) 2 /2|r| 2 and A T 0 /(1 + BT ) are, respectively, the 'kinetic' and 'potential' energies. The equation for BT describes the motion of a 'particle' of 'mass' 1/|r| 2 in in a potential field (23) . Furthermore, solving the energy conservation equation
The function BT /(1 + BT ) ∈ [0, 1] is monotonic increasing and concave for BT ≥ 0. Hence t B(t) is bounded from above by 2A T 0 |r| 2 t and this bound is saturated as t → ∞. Also, the (normalised) amount of target antigen AT (b(t))/AT (0) = (1 + BT (t)) −1 is bounded from below by (1 + 2A T 0 |r| 2 t) −1 . In a similar manner we simplify the dynamics of BS, which is also conservative, describing the motion of a particle of mass |r S | −2 and potential energy −γA S 0 /(1 + BS). Here we find
Since γ > 0 and with the assumed initial conditions, the (trivial) solution is BS = 0, i.e. self-reactive Abs are not used.
We have now seen that [20] can be mapped into equations of Classical Mechanics. The equation for BS describes the acceleration of a particle of mass |r S | −2 in a gravitational field with gravitational constant γ, created by a another particle of mass A S 0 and radius one (23) . The equation for BT has a similar interpretation but with a repulsive potential.
Ag removal is faster in a more diverse repertoire, and slower when the repertoire has higher self-reactivity. We return to the more general case where r · r S > 0, so Abs may have the potential to bind both target Ag and self Ag. Further analytic results can be obtained in the equilibrium regime of [18] , defined by d 2 BT /dt 2 = d 2 BS/dt 2 = 0. This can only occur when rµ = αr S µ for all µ (see SI, Section 2B) , where α > 0. The inverse α −1 can be seen as a degree of self-reactivity. From [17] it follows that BT = αBS in this regime, and that [18] can be reduced to a single equation:
with β = A T 0 /A S 0 . It is easy to show, using the above equation and [19] , that now d 2B /dt 2 = (r S · 1)|r S | −2 d 2 BS/dt 2 , and hence the average concentration of Abs is given byB
[25]
The dynamics [24] is again conservative, now with energy
As before we can use energy conservation, following initial conditions BS(0) = (dBS/dt)(0) = 0, to derive
From this follows the following upper bound, which is saturated as t → ∞ (see SI, Section 2B):
with the time constant
As a consequence of [28], we find for the normalised target Ag
So τ /α is a lower bound for the half-life of free target Ag; to achieve AT (b(t))/AT (0) = 1 2 , the required time t has to be at least τ /α. The lower bound for the half-life of self-Ag, derived by a similar argument, is found to be τ . Furthermore, if we define 2 and m λ (r S ) = (r S · 1)/w(λ) are, respectively, variance and mean of the selfaffinities r S (see SI, Section 2B). Thus τ is monotonically decreasing with the variance σ 2 λ (r S ) and the mean m λ (r S ). Since the former can be seen as a measure of the repertoire's 'diversity', having a more diverse repertoire facilitates a more rapid reduction of target Ag.
We also solved the differential equation [24] numerically for different inverse self-reactivities α. The solutions are plotted in Supplementary Information, in Figures 5-8 . Comparison of the upper bound [28] with the solutions of [24] in Figure  9 allows us to summarise various regimes. We first define, using [7] , the normalised damage per unit time δA(t1 − t0) = DA (t1 − t0) /AT (b(t0)) (t1 − t0), where 0 ≤ δA ≤ 1, and, using [8] , the normalised damage to self per unit [16] , on the time interval [0, t], the above definitions give us
[32]
Now since (1 + αBS) −1 is a monotonic decreasing function of BS, the upper bound [28] gives us the lower bounds
[34]
The latter gives us the upper
The two bounds on damages are plotted in Figure 2 for different values of self-reactivity constant α. For a repertoire with Abs binding α times stronger to the target Ag than to the self-Ag the immune response is 'normal' and 'autoimmune', respectively, when α > 1 and α < 1. The normal response is characterised by a large decrease of free target Ag and a small decrease in free self-Ag per unit of time. For the autoimmune response it is the opposite. Furthermore, the normal response is 'accelerated' by a larger α and increased repertoire diversity, but, for the same repertoire diversity, the autoimmune response is slower.
Discussion
In this work we have shown, using only minimal assumptions, that antibody repertoire diversity is important in the effective removal of antigen, in multiple ways. Not just because the repertoire will then have more chance of containing a single dominant antibody that can react to the target-Ag, but also because for a more diverse repertoire the half life of target-Ag will be smaller. Hence any decrease in repertoire diversity, such as that observed in older age, or caused by a prior immune response, can have an adverse effect on the immune response to challenge. Furthermore, reduction in efficacy of central tolerance mechanisms such as can occur in older age, will result in greater self-reactivity in the repertoire, and this too will hamper an efficient immune response against target-Ag.
The mathematical framework in the form developed here can for now only be used to model the immune response to a finite amount of Ag, with a fixed repertoire of Abs. Adaptation of the affinities of Abs to target Ag via affinity maturation (22) is not yet included. To model the latter on could modify the Lagrangian [9] , and derive dynamic equations for affinities. Also the present restriction on the amount of Ag can be relaxed within the current framework, by introducing (partially stochastic) Ag reproduction and death.
Materials and Methods
The Variational Problem. We aim to find the path b(t) that minimises the action [6] 
is any perturbed path with δb(t 0 ) = δb(t 1 ) = 0 (24). Using the differential operator ∇ b = (∂/∂b 1 , . . . , ∂/∂b M ) this difference, up to the order O |δb| 2 , can be written in the form 
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where we used integration by parts and the stated boundary conditions. Solving δS = 0 for the part of δS that is linear in δb gives us the so-called Euler-Lagrange equation
with boundary conditions b(t 0 ) = b 0 and b(t 1 ) = b 1 .
Mean-Field Limit. Here we explain briefly the derivation of [16] from [14] . Substituting rµ → rµ/M and r S µ → r S µ /M into [14] gives
, then for M → ∞ we will indeed find the mean-field expressiom [16] since
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Chemical kinetics of antigen-antibody reactions
[39]
In chemical equilibrium (25) 
[40]
Upon denoting the initial concentrations of the species •u, v , Iµ and P by [•u] 0 , [ v ] 0 , [Iµ] 0 and [P] 0 , we can use mass conservation to write
[
[ [
Finally, upon introducing the notation A S u and A T v for the concentrations [•u] of free self Ags and [ v ] of target Ags we obtain the following system of recursive equations, which, given the initial concentrations
can be used to obtain the equilibrium concentrations of free self and target Ag:
,
[46]
[Iµ] = bµ
We assume that the individual antibody affinities are weak, i.e. r S µu ≡ r S µu /M and rµv ≡ rµv/M , and consider
, where we have defined the normalised concentrationsÃ 
where 
Inserting this into equation [48] leads us for b = 0 to
Here we have defined the following two macroscopic observables:
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Finally, for the normalised self-AgÃ S u = A S u /A S u (0) and the normalised target AgÃ T v = A T v /A T v (0) we proceed in a similar way and obtain the equationsÃ 
[54]
These expressions hold when b = 0. If b = 0 we simply have A S u = A S u (0) and A T v = A T v (0). We note that the affinity parameter limit r → ∞ and the repertoire size limit M → ∞ commute. The meaning of the first limit is that the forward rate of the reaction AbAg + P AbAgP in [39] is much larger than the backward rate, i.e. K + K − . This limit enables us to use the present equilibrium framework to describe also irreversible processes, such as Ag 'removal' reactions like AbAg + P AbAgP (26) . 
The equations in [54] are functions of the sum y
Let us assume that the relevant solution of [56] is given by the function
, so that the solution of the recursion [54] is given by
and the concentrations of (total) free self-Ag and target Ag are
[58]
For P (0) = 0, i.e. in the absence of binding of Ag-Ab complexes to phagocytes, the above expressions simplify significantly to
so the concentration of free Ag decreases with increasing concentrations of Abs. In Figure 3 The e↵ect of this perturbation is to increase (or decrease) amount of available Ag and hence it models spontaneous "birth", ↵(t) 2 (1, b), or "death" of the Ag. Assuming that A is a A -homogeneous, where A 2 R, function of epitopes 6 gives us
for some real . Furthermore, the antibody dynamics (8) is also becomes perturbed and is given by the equation
where we assumed that f µ is also a homogeneous function of epitopes. For µ > 0 the function ↵ µ (t) is a monotonic increasing in ↵(t), so it is clear that the increase in Ag, due to its division, leads to the increase in Abs.
Let us assume that ↵(t) = 1 + e x(t) where
where ⌘(t) is a zero-average Gaussian noise with h⌘(t)⌘(t 0 )i = 2⌧ (t t 0 ). For t ! 1 the random variable x(t) is governed by the distribution
6 This is mathematically convenient but what is the physical meaning of this assumption? 
[60]
Its determinant
is positive when A T (0) + A S (0) ≥ P (0), in which case the equation has two real solutions. Only one of them is positive:
B. Bivalent Antibodies reacting with univalent target Antigen and self-Antigen. In this section we show that in the regime of 'weak' Abs, as considered in previous section, the amount of free Ag is not affected by the valency of Abs (22) . To this end it is sufficient only to consider the case of bivalent Abs interacting with univalent target Ag and self-Ag. In particular we consider M different bivalent Abs, represented by the symbols Yµ with µ ∈ {1, . . . , M }, forming complexes with univalent target Ag, , and univalent self-Ag, •. The formation of complexes is modelled by the following chemical reactions:
In chemical equilibrium, the concentrations of free self-Ag, target Ag, and Ab, which will be denoted, respectively, by the symbols .
[65]
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If the initial concentrations of species Using the equilibrium relations [65] in the above three lines now gives us
[68] Finally, with the notation Figure 6 : Network of M di↵erent populations of univalent antibodies (small blue circles) interacting with populations of the univalent antigen (red triangle) and self-antigen (blue circle). Population of the antibody µ is interacting with the antigen and self-Ag with, respectively, the 'strength' r µ , i.e. a nity , and r S µ . Population of antigens is interacting with all antibodies.
we obtain the recursive equations
Let us define the averages
where in above we used the definition of inner product (58) 
The simplest case to consider is when each Ab is either self-reactive or nonself-reactive, i.e. for Ab µ either the a nity to non-self r µ = 0 and self r S µ > 0 or the a nity r µ > 0 and r S µ = 0. The latter implies that hr, r S i = 0, in the system of equations (70), giving us the two equations 
with the short-hand x · y = M −1 M µ=1 λ −1 µ xµyµ, with associated inner product norm |x| = √
x · x.
In the special simplified case where each Ab µ interacts with only one type of Ag, we will have rv · r k = 0 if v = k, rv · r S = 0, etc., and the system of equations [74] simplifies to
We note that the above simplified macroscopic dynamics is conservative (23), with the energy function
where the first two terms play the role of 'kinetic' energies, and the third term is the 'potential' energy. The factors 1/|rv| 2 and 1/|r S u | 2 can be seen as 'masses'. So [76] describes the motion (23) of M A + M S 'particles', with distinct masses, in a potential field with potential energy [73] .
Let us now assume that the numbers of target and self Ags are equal, i.e. M A = M S , and that each Ab µ simultaneously interacts with two types of Ag, one target and one self (see Figure 4 for M A = M S = 1). Then the affinity vectors rv and r S u satisfy the orthogonality conditions rv · r k = 0 if k = v and r S u · r S = 0 if = u, i.e. each row in the affinity matrices R T = (r 1 , . . . , r M A ) and R S = (r S 1 , . . . , r S M A ) has exactly one positive component. Also rv · r S = 0 if = u, so, up to a permutation of columns, the matrices R T and R S are the same. Our equations then simplify to
[78]
Assuming that the above system is in 'mechanical' equilibrium,
[79]
and hence (rv · r S u ) 2 = |r S u | 2 |rv| 2 .
[80]
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We note that this will be true if and only if r = α(v, u)r S u , for some α(v, u) > 0. Using this in [77] gives us the equations
We note that α(v, u) generates a mapping rv = α(v, u) r S u between the affinities rv and r S u . Without loss of generality, we can always re-label the antibodies such that u = v, so that we only need α(v, v) ≡ α(v). Equation [81] can then be simplified to
where the partial derivatives are evaluated at
The macroscopic dynamics [83] is conservative when P (0) = 0. In this case the potential energy [73] is given by
and equation [83] reduces to
so this dynamics is conservative, with the energy
describing the 'motion' a 'particle' of 'mass' 1/|r S v | 2 in a potential field. If at time t = 0 we are given the initial position B S v (0) and velocity (dB S v /dt)(0) of this particle, then for all t > 0 we have due to energy conservation: Figure 4 ). Here the Euler-Lagrange equation is
The latter two macroscopic observables are governed by the equations 
[90]
The simplest case is that where each Ab is either self-reactive or non-self-reactive (never both), i.e. for all µ either rµ = 0 and r S µ > 0 or rµ > 0 and r S µ = 0. This implies that (r · r S ) = 0 in [89], giving us the two independent equations
[91]
We note that above is a special case of [76], so the dynamics of B T is conservative with the energy
Since energy is conserved, one can then use the identity E(B T , dB T /dt) = E (B T (0), (dB T /dt)(0)) to obtain a simple equation for dB/dt. For the initial conditions (dB T /dt)(0) = B T (0) = 0 this equation is given by
[93]
The function B/(1+B) ∈ [0, 1] is monotonic increasing and concave for B ∈ [ 0, ∞). Hence B T (t) is bounded from above by 2A 0 |r| 2 t, saturating this upper bound as t → ∞. Furthermore, the (normalised) amount of antigen A T /A(0) = 1/(1+B T (t)) is bounded from below by 1/(1+ 2A 0 |r| 2 ) t. Also the dynamics of B S in [91] is conservative, with energy
and using E(B S , dB S /dt) = E(B S (0), (dB S /dt)(0)), with initial conditions (dB S /dt)(0) = B S (0) = 0, gives us the equation
which for γ > 0 has only the trivial solution B S = 0. Values γ < 0 lead to self-antigen removal and hence are not desirable. Further results for [89] can in equilibrium states, defined by d 2 B T /dt 2 = d 2 B S /dt 2 = 0. From these conditions we infer that (r · r S ) 2 = r 2 (r S ) 2 , hence rµ = α r S µ for some α > 0. This, in return, via the definitions of B T and B S , implies B T = αB S and hence the system [89] reduces to a single equation:
where we defined β = A 0 T /A 0 S . Furthermore, for equation [90] , governing the average concentration of antibodiesB, we obtain
[97]
Thus the two equations [96] and [97] are related according to |r S | 2 d 2B /dt 2 = (r S · 1)d 2 B S /dt 2 , and hencẽ
[98]
The dynamics [96] conserves the energy
[99]
and we can use
[100]
Let us assume that B S (0) = (dB S /dt)(0) = 0 then this simplifies to
The argument of the square root above is non-negative if 
and hence
If the above monotonicity condition [103] is satisfied, then
where τ is the time constant
Furthermore, for α > 1 the RHS of [101] has a has a maximum at
when Taking the limit B S ! 1 in the RHS of (94) gives uṡ
If the condition in (97) is satisfied then
where c = p 2A S (0) |r S | 2 ( ), is an upper bound for the solution of (94). Furthermore, for ↵ > 1 the RHS of (94) has a has a maximum at
when
which gives us the upper bound (100) with
We solve the equation (83) numerically in the regimes (97) and (102) for a given , A S (0)|r S | 2 . The solutions of this equation are plotted in Figures 7-10 . Also we compare the upper bound (100) with a solution of (83) in Figure 11 . The upper bound allows us to summarise various regimes of the univalent Ag binding experiment in one 'figure as follows.
Let us now consider the normalised version
26 where 0  A  1, of the damage (12) and the normalised version
where 0  S  1, of (17). The latter gives us the (normalised) self-damage 0  1 S  1. For the mean field system (??), on the time interval [0, t], above gives us So here the time constant in [106] is different, and given by
[110]
We Figure 9 .
Let us now consider the normalised damage per unit of time
where 0 ≤ δ A ≤ 1, and a similar integral
where 0 ≤ δ S ≤ 1, which defines the (normalised) self-damage per unit of time 1 − δ S , where 0 ≤ 1 − δ S ≤ 1. For the scenario described by the equation [96] , on the time interval [0, t], the above expressions give us
[113]
Since 1/(1 +αB) decreases monotonically with B, from B S (t) < t/τ we obtain for the regime [103] the two lower bounds
with the time constant . Due to the inequality log (1 + x) ≥ 1 − (1 + x) −1 , this derivative is negative for any finite x, so δ * (x) is a monotonic decreasing function with δ * (x) → 1 as x → 0 and δ * (x) → 0 as x → ∞. Since the image of δ * (x) is the interval [0, 1] the function 1 − δ * (x) is monotonic increasing on the same domain. It follows that δ * A (t) → 1 as t → 0, implying that the (normalised) damage δ A (t) → 1 in this limit, and δ * A (t) → 0 as t → ∞. Also 1 − δ * S (t) → 0 as t → 0, implying that the self-damage 1 − δ S (t) → 0 in this limit, and 1 − δ * S (t) → 1 as t → ∞. For α = 1 (where the strengths of antibody interaction with non-self and self are identical) we obtain δ * A = δ * S and the damage δ * A (lower bound) is linearly related to the self-damage he self-damage 1 − δ * S (upper bound) via δ * A = 1 − (1 − δ * S ). For α < 1 (where the strength of antibody interaction with self is greater than the interaction with non-self) we obtain δ * A > 1 − (1 − δ * S ), so for a small reduction in the damage δ * D R A F T Figure 10 : The (average) amount of antibodies, B S , rateḂ S and (normalised) antigen A, (top blue curve is the self-antigen and bottom red curve is the antigen) plotted as a function of time t for A S (0) |r S | 2 = 10, ↵ = 0.1, = 0.01 and = 0.009. function of the variance σ 2 (r S ) and the mean m(r S ) of the vector of affinities r S , i.e. of the antibody repertoire. Thus, having a repertoire with a higher variance facilitates a more rapid Ag removal.
